Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort study

Abstract

Our nationwide study demonstrated a survival benefit over conventional chemotherapy of a similar magnitude as observed in clinical trials and confirms the effectiveness of pembrolizumab in routine clinical practice.